Newsroom

Sorted by: Latest

-

Ensayos clínicos de hematología y oncología: AOP Health presenta nuevos resultados en el prestigioso congreso de la ASH

VIENA--(BUSINESS WIRE)--AOP Health sigue avanzando en su programa de investigación clínica en neoplasias mieloproliferativas, un grupo particular de cánceres sanguíneos poco frecuentes. La empresa, especializada en enfermedades raras, presentó los resultados de dos estudios científicos en la 67.a Reunión Anual 2025 de la Sociedad Estadounidense de Hematología (ASH, por sus siglas en inglés), realizada en Orlando, Florida, EE. UU. Estos hallazgos aportan nuevos conocimientos sobre las estrategia...
-

台灣原創SNQ認證機制躍上國際 攜手ICHOM引領亞太醫療品質標準

台北--(BUSINESS WIRE)--(美國商業資訊)-- 在台灣推動28年的SNQ國家品質標章,12月6日在「亞太醫療品質年會」上,由總召集人陳維昭,與國際健康照護成效評估聯盟(ICHOM)執行長布萊特(Jennifer L. Bright)簽署合作協議。台灣原創的SNQ品質認證機制,正式成為ICHOM亞洲第一個合作夥伴。 透過此次合作,SNQ將已發展成熟的品質認證機制,更進一步結合ICHOM知名的「病人回報成果量測」(PROMs)標準,讓本土醫療品質系統與國際標準接軌,不但能提升台灣醫療品質的國際曝光度,並使台灣醫界共同成就的SNQ醫療品質認證,在全球展現更大影響力。 陳維昭表示,台灣醫療28年來歷經SNQ國家品質標章機制,水準持續提高,與國際趨勢並進,此次和ICHOM合作,SNQ的經驗與方法能給更多國際醫療體系參考,並使獲SNQ標章的團隊被世界看見。 SNQ累計2,900件認證 打造台灣最具代表性的品質體系 自1998年創立至今,SNQ已完成超過2,900件跨領域認證,涵蓋特色醫療、醫事服務、管理、護理、長照與社區服務等。SNQ匯聚百位以上醫界專家,以「結構→過程→結果」三階...
-

Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney

--(BUSINESS WIRE)--Gartner will explore “Autonomous Finance: Building Resilient, AI-Driven, and Value-Centric Enterprises” during the Gartner Finance Symposium/Xpo....
-

Fitch Learning przejmuje Moody’s Analytics Learning Solutions i Canadian Securities Institute

NOWY JORK--(BUSINESS WIRE)--Fitch Learning, światowy lider w dziedzinie edukacji finansowej i profesjonalnej certyfikacji, poinformował dzisiaj o finalizacji transakcji przejęcia Moody’s Analytics Learning Solutions (MALS) oraz Canadian Securities Institute (CSI). MALS jest globalnym dostawcą szkoleń kredytowych i cyfrowych, a CSI to czołowy dostawca usług certyfikacyjnych na rzecz kanadyjskiego sektora usług finansowych. Fitch Learning, firma ciesząca się ogólnoświatową renomą wiodącego dostaw...
-

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implemen...
-

Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Eagle Pharmaceuticals, Inc. (OTCPK: EGRX) breached their fiduciary duties to shareholders. If you currently own Eagle stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about yo...
-

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If you currently own Lifecore stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about...
-

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

VIENNA--(BUSINESS WIRE)--AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use...
-

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with MF Presented at ASH 2025...
-

Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA...